Inogen (INGN)
(Real Time Quote from BATS)
$8.12 USD
+0.05 (0.62%)
Updated Jun 5, 2024 02:48 PM ET
2-Buy of 5 2
C Value A Growth B Momentum A VGM
Brokerage Reports
0 items in cart
Inogen, Inc [INGN]
Reports for Purchase
Showing records 101 - 120 ( 284 total )
Company: Inogen, Inc
Industry: Medical - Instruments
Provider: Zacks Investment Research
Analyst: Research Department
Company: Inogen, Inc
Industry: Medical - Instruments
Company: Inogen, Inc
Industry: Medical - Instruments
Provider: Zacks Investment Research
Analyst: Research Department
Company: Inogen, Inc
Industry: Medical - Instruments
Provider: Zacks Investment Research
Analyst: Research Department
Company: Inogen, Inc
Industry: Medical - Instruments
Company: Inogen, Inc
Industry: Medical - Instruments
Company: Inogen, Inc
Industry: Medical - Instruments
Company: Inogen, Inc
Industry: Medical - Instruments
Company: Inogen, Inc
Industry: Medical - Instruments
Provider: Zacks Investment Research
Analyst: Research Department
Company: Inogen, Inc
Industry: Medical - Instruments
Company: Inogen, Inc
Industry: Medical - Instruments
Provider: Zacks Investment Research
Analyst: Research Department
Company: Inogen, Inc
Industry: Medical - Instruments
Company: Inogen, Inc
Industry: Medical - Instruments
Provider: Zacks Investment Research
Analyst: Research Department
Company: Inogen, Inc
Industry: Medical - Instruments
MedTech: Up a Creek Without a Clear Timeline
Provider: KEYBANC CAPITAL MARKETS
Analyst: Research Department
Company: Inogen, Inc
Industry: Medical - Instruments
Provider: Zacks Investment Research
Analyst: Research Department
Company: Inogen, Inc
Industry: Medical - Instruments
Provider: Zacks Investment Research
Analyst: Research Department
Company: Inogen, Inc
Industry: Medical - Instruments
Company: Inogen, Inc
Industry: Medical - Instruments
Vaccinations May Be Jump-Starting Typical Seasonality and Its Recovery
Provider: KEYBANC CAPITAL MARKETS
Analyst: Research Department
Company: Inogen, Inc
Industry: Medical - Instruments
Updating Estimates for Last Week''s Positive 1Q21 Sales Pre-Announcement
Provider: KEYBANC CAPITAL MARKETS
Analyst: Research Department